Acerus to Report First Quarter 2020 Financial Results and Host Investor Call
Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will
announce its first quarter 2020 financial and operating results on
Tuesday May 12, 2020 before the market opens. The company will host
a conference call on Tuesday, May 12, 2020 at 8:30 a.m. Eastern
To access the call live, please dial 416-406-0743 or
1-800-898-3989 and use access code 8842272#. Listeners are
encouraged to dial in 10 minutes before the call begins to avoid
delays. A replay of the conference call will be available until
11:59 p.m. Eastern Time on Tuesday, May 19, 2020 by dialing
905-694-9451 or 1-800-408-3053, using access code: 5893931#.
Acerus Pharmaceuticals Corporation is a Canadian-based specialty
pharmaceutical company focused on the commercialization and
development of innovative prescription products that improve
patient experience, with a primary focus in the field of men’s
health. The Company commercializes its products via its own
salesforce in the United States and Canada, and through a global
network of licensed distributors in other territories.
Acerus’ shares trade on TSX under the symbol ASP and on OTCQB
under the symbol ASPCF. For more information, visit
www.aceruspharma.com and follow us on Twitter and LinkedIn.
version on businesswire.com: https://www.businesswire.com/news/home/20200505005306/en/
Acerus Pharmaceuticals Corporation Robert Motz Chief Financial
Officer firstname.lastname@example.org (905) 817-8288